CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
IL-6 mediated JAK/STAT3 signaling pathway in cancer patients with cachexia
Authors
A. Y. Men
B. N. Kucukakca
+12 more
Cemil Bilir
Cemil Bilir
D. Akpinar
Deveci A. Ozkan
Asuman Deveci Özkan
E. Bezdegumeli
Guney G. Eskiler
Gamze Güney Eskiler
M. N. Ince
O. Aktas
Y. E. Horoz
Z. Ozman
Publication date
1 January 2019
Publisher
'AEPress, s.r.o.'
Doi
Cite
Abstract
CONCLUSION: STAT3 may be considered as a therapeutic target for cachectic patients with gastric, lung and breast cancer. Furthermore, IL-6 mediates STAT3 activation in cachectic gastric and breast cancer patients (Tab. 5, Fig. 2, Ref. 62)
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Sakarya Üniversitesi Kurumsal Açık Akademik Arşivi
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:acikerisim.sakarya.edu.tr:...
Last time updated on 20/03/2020
Sakarya Üniversitesi Kurumsal Açık Akademik Arşivi
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:acikerisim.sakarya.edu.tr:...
Last time updated on 20/03/2020
